Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
about
Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular diseaseApolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patientsStructure of apolipoprotein C-IIToronto, a nonfunctional human apolipoproteinThe human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organizationApolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemiaIsolation and nucleotide sequence of a full-length cDNA coding for aldolase B from human liverAmino acid sequence of human plasma apolipoprotein C-III from normolipidemic subjectsRetinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptorA frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacitiesDifferential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor exHost-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants.Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemiaMolecular cloning and nucleotide sequence of cDNA for murine senile amyloid protein: nucleotide substitutions found in apolipoprotein A-II cDNA of senescence accelerated mouse (SAM).The human ryanodine receptor gene: its mapping to 19q13.1, placement in a chromosome 19 linkage group, and exclusion as the gene causing myotonic dystrophy.Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-1 C-III A-IV gene region and hypertriglyceridemia.Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptorHuman apolipoprotein B cDNA clone isolation and demonstration that liver apolipoprotein B mRNA is 22 kilobases in lengthModified oligonucleotides as alternatives to the synthesis of mixed probes for the screening of cDNA libraries.Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations.AvaII RFLP at the human apolipoprotein CII (APO CII) gene locus.Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.Post-translational modification of apolipoprotein B by transglutaminasesLinkage analysis of the apolipoprotein C2 gene and myotonic dystrophy on human chromosome 19 reveals linkage disequilibrium in a French-Canadian population.Biomarkers of necrotizing enterocolitis: a review of literature.Expression of the human apolipoprotein AI gene fused to the E. coli gene for beta-galactosidase.The human preproapolipoprotein C-II gene
P2860
Q24561663-BC141EF8-29E0-4791-B94B-70EBE34EB9B5Q24564101-1D986B9D-1102-48F5-84BC-36F5C016C93CQ24618630-94407CA2-62C1-4218-A0E7-57F025102C5EQ24626787-C2B9E8BC-B1CC-4140-8C98-C5489A135D8CQ24633209-509D9CC8-037D-498A-AD62-62726CCDF5AFQ24634399-F46E1260-0604-45C5-B581-B44B0A11030AQ28307638-E712BE84-E11E-4D61-8323-B92226F6614EQ28378880-6150333F-A300-4FBC-950F-F4F7B92A7B59Q33382898-8E4DEB27-D5BC-4D6F-B73A-57DABB2D3013Q33952364-DDDD8DE7-2A57-4111-9332-A314ED451EEAQ34028660-3E862684-A39C-436B-BA74-CA5244A99177Q34554317-713E2107-4C45-4A5A-ACED-FB7672ACD70BQ35047696-5165E3A7-C331-425F-8CB1-6BFD0C68B3B2Q35198353-DCD0D628-E62B-4B35-8636-8D272176E45BQ35199258-1833DB9D-72AF-4B75-A089-8E8350B5211EQ35752132-0A136EBC-DF61-49A8-B015-4CF42AF0B863Q36423961-313DB77F-6C62-44BE-AAA4-77C63E52C17DQ36487052-4388935D-D285-4E99-B56A-7F4250A59FDDQ36503047-B41D08D1-C1B8-48C5-B141-AE91436DF85CQ37900093-05677414-5BC6-4167-B64A-B7EE9E97083AQ40390035-4DD7F412-F2A3-4DD3-9AC2-2ACC967CE187Q40822165-175D3947-493C-4D58-92C3-588E49C897D0Q41811430-E3434C17-49C8-4B42-A7B9-EBE5045D20EEQ43105676-A68F9057-E023-4284-9530-B9F90CC0B210Q54782705-C8CDE938-3566-40B9-A9AB-C0A946F50D41Q54785187-A0052735-2270-4D6E-AEC9-8141E7B67BCBQ56602277-FE097B4A-3593-4B55-94B1-E0C6AAAC2635
P2860
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
description
1984 nî lūn-bûn
@nan
1984 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
name
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@ast
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@en
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@nl
type
label
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@ast
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@en
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@nl
prefLabel
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@ast
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@en
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@nl
P2093
P2860
P356
P1476
Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance
@en
P2093
C C Shoulders
C S Shelley
F E Baralle
M A Lucero
P2860
P304
P356
10.1093/NAR/12.9.3917
P407
P50
P577
1984-05-01T00:00:00Z